Archives of Clinical Infectious Diseases
Abdolaziz Rastegar Lari1,*, 
Alireza Ghaffariyeh2, Noushi Etesam3, Hamid Mostafavi3, Reza Alaghehbandan4Acute sinusitis constitutes a significant portion of health service utilization globally both in- and outpatient as well as emergency department visits, with 83% resulting in a prescription for an antibiotic. This study compared the efficacy of a 5-day regimen of azithromycin (a macrolid antibiotic) with a 10-day regimen of coamoxiclav (combination of an aminopenicillin with a betalactamase inhibitor) for the treatment of acute sinusitis.
A total of 76 subjects with acute sinusitis were randomly assigned in two groups, azithromycin (n=40) and co-amoxiclav (n=36). One group received azithromycin, 500mg in the first day and 250mg for 4 days and the other group received co-amoxiclav 625mg, 3 times a day for 10 days. Patients were visited 4 times during the study (baseline, phone call, end of treatment, end of study) and regression/progression of their symptoms and their response to the treatment was evaluated.
There was no significant difference between the two groups' demographic and clinical presentations. Duration of regression of the symptoms in the azithromycin group was significantly shorter than the co-amoxiclav group (7.6 days versus 10.6, p=0.03). Clinical success rate at end of the study was 80% for azithromycin and 66.7% for co-amoxiclav (p=0.025). Clinical success rates among females in both groups seemed to be higher than males, but this difference was not statistically significant (p=0.13).
Results revealed that azithromycin regimen is more efficient, has less side effects, and required shorter treatment period. Patients were able to tolerate the medications better with a higher compliance and less economic cost than co-amoxiclav regimen.
© 2010, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.
Amini M, Yarmohammadi M, Izadi P. A comparing Study of Clarithromycin XL with Co-Amoxiclav for Treatment of Chronic Sinusitis; a Clinical Trial. Arch Clin Infect Dis. 2009;4(4):. doi:
Maneshi A, Modaresi MR, Khalili H, Shojae L, Faghihi T. Nebulized Azithromycin Versus Oral Azithromycin as Anti-Inflammatory Therapy in Children with Cystic Fibrosis: A Prospective Randomized Open-Label Trial. Inn J Pediatr. 2019;29(6):e96977. doi: https://doi.org/10.5812/ijp.96977
Koochak Alavi S. The comparison of different antibiotics in treatment of acute otitis media in children. J Inflamm Dis. 2024;8(4):e155082. doi:
Saki N, Nikakhlagh S, Kalantari H. STUDY OF SHORT USE OF PREDNISONE IN THE TREATMENT OF MIDDLE EAR EFFUSION. Jundishapur J Nat Pharm Prod. 2006;1(1):. doi:
Aslani A, Fathi A. Formulation and Evaluation of Co-Amoxiclav 228 and 312 mg Dispersible Tablets. J Rep Pharm Sci. 2016;5(1):e147656. doi:
Last Update: 3 weeks ago
Last Update: 3 weeks ago
Last Update: 3 weeks ago
Last Update: 4 days ago
Ordering Reprints
Articles are published under the Creative Commons license stated on each article. No permission or royalty fee is required for uses permitted by that license. CCC handles optional bulk and customized reprint orders. Any quotation covers production and delivery services only, not copyright permission. > Request Reprints from CCC
Author(s):
